Artelo Biosciences ARTL
NASDAQ ARTL
$5.98 -0.21 (-3.39%)
At close: Sep 9, 2026 · 4:00 PM EDT

Artelo Biosciences (ARTL) Research & Development (2017 - 2025)

Artelo Biosciences' (ARTL) quarterly Research & Development came in at $893000.0 in Q4 2025, down 63.93% year-over-year from $2.5 million in Q4 2024, and down 29.96% quarter-over-quarter from $1.3 million in Q3 2025.

Analysis

Artelo Biosciences (ARTL) Research & Development (2017 - 2025) Analysis & Trends

Artelo Biosciences (ARTL) has reported Research & Development for 9 consecutive years, with $893000.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Research & Development fell 63.93% year-over-year to $893000.0 in Q4 2025; TTM through Dec 2025 was $5.4 million, a 9.51% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, down 9.51% from the prior year.
  • Research & Development was $893000.0 for Q4 2025 at Artelo Biosciences, down from $1.3 million in the prior quarter.
  • Over five years, Research & Development peaked at $2.5 million in Q4 2024 and troughed at $325000.0 in Q3 2024.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2021 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development tumbled 79.5% in 2024 and surged 292.31% in 2025, its largest moves.
  • Over 5 years, Research & Development stood at $1.3 million in 2021, then soared by 35.59% to $1.7 million in 2022, then rose by 23.06% to $2.1 million in 2023, then rose by 16.57% to $2.5 million in 2024, then sank by 63.93% to $893000.0 in 2025.
  • The last three Research & Development figures came in at $893000.0 (Q4 2025), $1.3 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 1.87 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 1.76 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 993.80 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 1.63 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -486.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 651.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 413.13 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 529.60 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 202.02 Mn
10 Artelo Biosciences 120,353.04 -479,646.96 - 893,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 893,000.00
Sep 30, 2025 1.28 Mn
Jun 30, 2025 1.87 Mn
Mar 31, 2025 1.38 Mn
Dec 31, 2024 2.48 Mn
Sep 30, 2024 325,000.00
Jun 30, 2024 1.69 Mn
Mar 31, 2024 1.51 Mn
Dec 31, 2023 2.12 Mn
Sep 30, 2023 1.59 Mn
Jun 30, 2023 752,000.00
Mar 31, 2023 1.24 Mn
Dec 31, 2022 1.73 Mn
Sep 30, 2022 1.08 Mn
Jun 30, 2022 1.06 Mn
Mar 31, 2022 464,000.00
Nov 30, 2021 1.27 Mn
May 31, 2021 951,204.00
Feb 28, 2021 663,359.00
Nov 30, 2020 595,000.00